Search Results - "Ver Donck, K."
-
1
Nucleoside transport inhibition and fMLP-stimulated whole blood luminescence
Published in Journal of molecular and cellular cardiology (01-07-1991)“…Adenosine (ADO) has a pharmacological profile which makes it an interesting 'drug' to handle many of the problems arising with ischemia and reperfusion. In…”
Get more information
Journal Article -
2
Structural interpretation of the amino acid sequence of a second domain from the Artemia covalent polymer globin
Published in The Journal of biological chemistry (25-08-1990)“…Artemia has a complex extracellular hemoglobin of Mr 260,000 comprising two globin chains (Mr 130,000) each of which is a polymer of eight covalently linked…”
Get full text
Journal Article -
3
Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection
Published in The Journal of clinical investigation (01-02-1995)“…In 12 healthy male volunteers (27-53 yr), a placebo-controlled randomized double blind cross-over trial was performed to study the effect of the intravenous…”
Get full text
Journal Article -
4
The implications of non-linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine
Published in British journal of clinical pharmacology (01-11-1996)“…1. Draflazine, a nucleoside transport inhibitor, was administered as a 15 min i.v. infusion of 2.5 mg to eight healthy male subjects. Plasma and whole blood…”
Get full text
Conference Proceeding Journal Article -
5
Population analysis of the non linear red blood cell partitioning and the concentration‐effect relationship of draflazine following various infusion rates
Published in British journal of clinical pharmacology (01-06-1997)“…Aims To investigate the impact of the specific red blood cell binding on the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor…”
Get full text
Journal Article -
6
Role of nucleoside transport inhibition and endogenous adenosine in prevention of catecholamine induced death in rabbits
Published in Cardiovascular research (01-01-1993)“…R 75,231, a potent and specific nucleoside transport inhibitor, largely prevents cardiac damage and death in catecholamine challenged rabbits. The major…”
Get more information
Journal Article -
7
Physiological red blood cell kinetic model to explain the apparent discrepancy between adenosine breakdown inhibition and nucleoside transporter occupancy of draflazine
Published in The Journal of pharmacology and experimental therapeutics (01-07-1998)“…A physiological red blood cell (RBC) kinetic model is proposed for the adenosine (ADO) transport into erythrocytes and its subsequent intracellular deamination…”
Get more information
Journal Article -
8
A.264 Draflazine Inhibits red blood cell adenosine transport during CPB
Published in British journal of anaesthesia : BJA (01-06-1996)Get full text
Journal Article -
9
The implications of non‐linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine
Published in British journal of clinical pharmacology (01-11-1996)“…1 Draflazine, a nucleoside transport inhibitor, was administered as a 15 min i.v. infusion of 2.5 mg to eight healthy male subjects. Plasma and whole blood…”
Get full text
Journal Article -
10
Comparison of the existing nucleoside transport inhibitors: in vitro and in vivo data
Published in Advances in experimental medicine and biology (1991)Get more information
Journal Article -
11
Prevention of catecholamine-induced cardiac damage and death with a nucleoside transport inhibitor
Published in Journal of cardiovascular pharmacology (01-08-1992)“…The effect of a potent and specific nucleoside transport inhibitor, R 75,231, on catecholamine-induced cardiac toxicity has been studied in rabbits…”
Get more information
Journal Article -
12
High-grade nucleoside transport inhibition stimulates ventilation in humans
Published in Journal of clinical pharmacology (01-04-1995)“…In 6 healthy male volunteers a placebo-controlled, double-blind, randomized, crossover trial was done to assess the effect of 1, 2, 4, and 6 mg of draflazine,…”
Get more information
Journal Article -
13
Purine metabolism in the heart. Strategies for protection against myocardial ischaemia
Published in Pharmacy world and science (15-04-1994)“…Adenosine has recently received much attention for the protection it provides against the deleterious effects of ischaemia reperfusion. Whenever the demand for…”
Get more information
Journal Article